{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T04:21:46Z","timestamp":1780633306216,"version":"3.54.1"},"reference-count":13,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Fulminant liver failure (FLF) is characterized by sudden hepatocellular necrosis, severe systemic inflammation, and rapid progression to multiorgan failure. Increasing evidence implicates intestinal barrier dysfunction and microbe-associated molecular pattern (MAMP) translocation as key drivers of hepatic injury through gut\u2013liver axis dysregulation. Probiotic-mediated modulation of epithelial integrity and mucosal immunity has shown promise; however, available data in FLF settings remain limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>\n                      This study examined whether continuous probiotic supplementation modulates intestinal epithelial barrier function, limits bacterial translocation, and reduces biochemical and histopathological indicators of hepatic damage in\n                      <jats:sc>d<\/jats:sc>\n                      -galactosamine\/lipopolysaccharide (GalN\/LPS)-induced FLF models.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Male Wistar rats were randomized into three groups: (i) healthy controls, (ii) FLF (700 mg\/kg GalN + 10 \u00b5g\/kg LPS, intraperitoneal), and (iii) FLF + probiotics. Animals in the probiotic group received a multistrain probiotic formulation (\n                      <jats:italic>Lactobacillus rhamnosus<\/jats:italic>\n                      GG,\n                      <jats:italic>Lactobacillus plantarum<\/jats:italic>\n                      ,\n                      <jats:italic>Bifidobacterium longum<\/jats:italic>\n                      ) at 10\n                      <jats:sup>9<\/jats:sup>\n                      CFU\/day orally for 14 days prior to FLF induction and continued until they were killed. Intestinal permeability was measured using serum FITC-dextran translocation. Tight junction protein profiles (ZO-1, occludin, claudin-1) were evaluated using Western blotting and confocal immunofluorescence. Hepatic damage was assessed by serum Alanine Aminotransferase (ALT), Aspartate Aminotransferase (AST), total bilirubin, alkaline phosphatase, and oxidative stress markers (MDA, GSH). Systemic irritation was characterized by measuring tumor necrosis factor alpha (TNF-\u03b1), interleukin (IL)-1\u03b2, and IL-6 using enzyme-linked immunosorbent assay (ELISA). Liver tissues were inspected for necroinflammatory changes utilizing H&amp;amp;E scoring and TUNEL assay.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Probiotic supplementation markedly reduced GalN\/LPS-induced intestinal hyperpermeability (\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.01) and protected tight junction architecture, as demonstrated by restored ZO-1 and occludin localization and increased claudin-1 expression. Treated animals exhibited notably significant increases in ALT, AST, bilirubin, ammonia, and oxidative stress markers (all\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.05). Cytokine profiling showed significant decreases in TNF-\u03b1, IL-1\u03b2, and IL-6 levels compared with untreated FLF animals. Histopathological analysis revealed reduced hepatocellular damage, decreased apoptotic cell burden, and lower composite liver injury scores in the probiotic group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Continuous probiotic administration provides critical protection against FLF by fortifying epithelial tight junction integrity, suppressing gut-derived inflammatory signaling, and limiting hepatocellular damage. These findings support the utility of targeted microbiota-directed interventions as adjunctive preclinical therapeutic strategies for acute liver failure and warrant further translational evaluation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcimb.2026.1751857","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T06:41:41Z","timestamp":1771569701000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of continuous probiotic supplementation on intestinal barrier function and hepatic biomarkers in fulminant liver failure models"],"prefix":"10.3389","volume":"16","author":[{"given":"Chaoyu","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Critical Care Medicine, The First Affiliated Hospital of Gannan Medical University","place":["Ganzhou, Jiangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songmao","family":"Ouyang","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, The First Affiliated Hospital of Gannan Medical University","place":["Ganzhou, Jiangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiying","family":"Lai","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, The First Affiliated Hospital of Gannan Medical University","place":["Ganzhou, Jiangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengbiao","family":"Xue","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, The First Affiliated Hospital of Gannan Medical University","place":["Ganzhou, Jiangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caixin","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, The First Affiliated Hospital of Gannan Medical University","place":["Ganzhou, Jiangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1080\/01480545.2024.2413409","article-title":"Probiotics modulation of the endotoxemic effect on the gut and liver of the lipopolysaccharide challenged mice","volume":"48","author":"Babu","year":"2025","journal-title":"Drug Chem. Toxicol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"6505","DOI":"10.1080\/10408398.2021.1902263","article-title":"Therapeutic modulation methods of gut microbiota and gut-liver axis","volume":"62","author":"Beyaz Co\u015fkun","year":"2022","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.688780","article-title":"Gut microbiota and chemical-induced acute liver injury","volume":"12","author":"Chen","year":"2021","journal-title":"Front. Physiol."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2024.1393014","article-title":"Fecal microbiota transplantation from female donors restores gut permeability and reduces liver injury and inflammation in middle-aged male mice exposed to alcohol","volume":"11","author":"Lamas-Paz","year":"2024","journal-title":"Front. Nutr."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1002\/jsfa.13057","article-title":"Limosilactobacillus fermentum HF06-derived paraprobiotic and postbiotic alleviate intestinal barrier damage and gut microbiota disruption in mice with ulcerative colitis","volume":"104","author":"Liu","year":"2024","journal-title":"J. Sci. Food Agric."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21218351","article-title":"The gut barrier, intestinal microbiota, and liver disease: molecular mechanisms and strategies to manage","volume":"21","author":"Plaza-D\u00edaz","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"C129","DOI":"10.1152\/ajpcell.00101.2023","article-title":"Pathogenetic mechanisms and therapeutic approaches of acute-to-chronic liver failure","volume":"325","author":"Schierwagen","year":"2023","journal-title":"Am. J. Physiology-Cell. Physiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/j.cmet.2022.09.017","article-title":"Gut-liver axis: Pathophysiological concepts and clinical implications","volume":"34","author":"Tilg","year":"2022","journal-title":"Cell Metab."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.739337","article-title":"Effectiveness of probiotics and prebiotics against acute liver injury: a meta-analysis","volume":"8","author":"Xu","year":"2021","journal-title":"Front. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1177\/15353702221126562","article-title":"Protective effects of glutamine on lipopolysaccharide\/D-galactosamine-induced fulminant hepatitis in mice","volume":"248","author":"Yang","year":"2023","journal-title":"Exp. Biol. Med."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.117656","article-title":"Ganoderma lucidum ethanol extracts ameliorate hepatic fibrosis and promote the communication between metabolites and gut microbiota g_Ruminococcus through the NF-\u03baB and TGF-\u03b21\/Smads pathways","volume":"322","author":"Zhang","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13062-024-00462-5","article-title":"Lactobacillus reuteri mitigates hepatic ischemia\/reperfusion injury by modulating gut microbiota and metabolism through the Nrf2\/HO-1 signaling","volume":"19","author":"Zhang","year":"2024","journal-title":"Biol. Direct."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2022.111673","article-title":"Lactobacillus reuteri improves function of the intestinal barrier in rats with acute liver failure through Nrf-2\/HO-1 pathway","volume":"99","author":"Zhou","year":"2022","journal-title":"Nutrition"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1751857\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T06:41:41Z","timestamp":1771569701000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1751857\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":13,"alternative-id":["10.3389\/fcimb.2026.1751857"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2026.1751857","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,20]]},"article-number":"1751857"}}